A detailed history of Acadian Asset Management LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 105,954 shares of ETON stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105,954
Previous 120,574 12.13%
Holding current value
$1.35 Million
Previous $395,000 60.51%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$3.28 - $6.0 $47,953 - $87,720
-14,620 Reduced 12.13%
105,954 $634,000
Q2 2024

Aug 06, 2024

SELL
$3.06 - $3.75 $109,584 - $134,295
-35,812 Reduced 22.9%
120,574 $395,000
Q1 2024

May 10, 2024

BUY
$3.48 - $5.03 $65,765 - $95,056
18,898 Added 13.75%
156,386 $585,000
Q4 2023

Feb 13, 2024

BUY
$3.45 - $4.66 $138,772 - $187,443
40,224 Added 41.36%
137,488 $601,000
Q3 2023

Nov 13, 2023

BUY
$2.55 - $5.63 $248,023 - $547,596
97,264 New
97,264 $403,000

Others Institutions Holding ETON

About Eton Pharmaceuticals, Inc.


  • Ticker ETON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,297,000
  • Market Cap $322M
  • Description
  • Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...
More about ETON
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.